Skip to main content

Table 1 The binding kinetics of DuAb or EDuAb to CD3 and CD19 protein

From: Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy

Method

Ligand

Analyte

Ka(1/Ms)

Kd(1/Ms)

KD(M)

Rmax(RU)

Fit Model

CM5

Human CD3E&CD3D hHeterodimer Protein

DuAb

3.14E + 05

2.63E-03

4.39E-08

402.1

1:1 binding

CM5

Human CD3E&CD3D hHeterodimer Protein

EDuAb

1.89E + 05

7.06E-04

3.82E-08

639.4

1:1 binding

CM5

Human CD19 Protein

DuAb

1.44E + 05

5.48E-02

3.80E-07

206.7

1:1 binding

CM5

Human CD19 Protein

EDuAb

2.55E + 05

1.65E-02

6.45E-08

85.3

1:1 binding